The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
This is a Phase 2, randomized, double-blind, placebo controlled, three arm study in adult men with biopsy confirmed NASH. The study is aimed at evaluating efficacy and tolerability of LPCN 1144 in adult men with NASH.
Epistemonikos ID: 1b7f86700ea806cc531598e2d9970149218a8149
First added on: Nov 24, 2021